rs1049654

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001001548.3(CD36):​c.-132A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.497 in 153,858 control chromosomes in the GnomAD database, including 19,521 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 19285 hom., cov: 32)
Exomes 𝑓: 0.49 ( 236 hom. )

Consequence

CD36
NM_001001548.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.283

Publications

24 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 7-80646139-A-C is Benign according to our data. Variant chr7-80646139-A-C is described in ClinVar as Benign. ClinVar VariationId is 360748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.548 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD36NM_001001548.3 linkc.-132A>C 5_prime_UTR_variant Exon 2 of 15 ENST00000447544.7 NP_001001548.1 P16671-1A4D1B1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD36ENST00000447544.7 linkc.-132A>C 5_prime_UTR_variant Exon 2 of 15 5 NM_001001548.3 ENSP00000415743.2 P16671-1

Frequencies

GnomAD3 genomes
AF:
0.497
AC:
75478
AN:
151874
Hom.:
19273
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.422
Gnomad AMI
AF:
0.507
Gnomad AMR
AF:
0.528
Gnomad ASJ
AF:
0.573
Gnomad EAS
AF:
0.322
Gnomad SAS
AF:
0.298
Gnomad FIN
AF:
0.532
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.521
GnomAD4 exome
AF:
0.488
AC:
910
AN:
1866
Hom.:
236
Cov.:
0
AF XY:
0.475
AC XY:
478
AN XY:
1006
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.488
AC:
210
AN:
430
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
3
AN:
8
East Asian (EAS)
AF:
0.190
AC:
8
AN:
42
South Asian (SAS)
AF:
0.216
AC:
38
AN:
176
European-Finnish (FIN)
AF:
0.333
AC:
2
AN:
6
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.540
AC:
615
AN:
1138
Other (OTH)
AF:
0.515
AC:
34
AN:
66
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.497
AC:
75519
AN:
151992
Hom.:
19285
Cov.:
32
AF XY:
0.493
AC XY:
36615
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.421
AC:
17477
AN:
41476
American (AMR)
AF:
0.528
AC:
8048
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.573
AC:
1991
AN:
3472
East Asian (EAS)
AF:
0.322
AC:
1658
AN:
5142
South Asian (SAS)
AF:
0.299
AC:
1439
AN:
4818
European-Finnish (FIN)
AF:
0.532
AC:
5598
AN:
10524
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.553
AC:
37597
AN:
67986
Other (OTH)
AF:
0.516
AC:
1091
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1944
3888
5831
7775
9719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.532
Hom.:
26752
Bravo
AF:
0.501
Asia WGS
AF:
0.304
AC:
1060
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Platelet-type bleeding disorder 10 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
8.4
DANN
Benign
0.86
PhyloP100
0.28
PromoterAI
-0.10
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1049654; hg19: chr7-80275455; API